Everand Logo

Welcome to Everand!

  • STAT

    Departure of top Haven executive creates void at a crucial stage

    Jack Stoddard left Haven after eight months as COO of the company founded by Amazon, Berkshire Hathaway, and JPMorgan Chase.
    by Casey Ross and Kate Sheridan May 17, 2019 2 minutes

    Jack Stoddard was the executive who understood how technology can fix health care services. He was a crucial early hire for Haven, the company formed by Amazon, Berkshire Hathaway, and JPMorgan Chase to lower costs and improve medical services for employees.

    But Stoddard’s departure this week, after only

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
    Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
    The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

    Related Books & Audiobooks